It was also found that the expression level of CtBP2 in prostate cancer tissues was higher than in normal tissues, which was closely associated with the malignant behavior of the tumor, indicated by elevated serum prostatic specific antigen (PSA) levels, advanced tumor stage (T3), high Gleason score, and positive extraprostatic extension [67]. This evidence concerns the gene PROS1 and neoplasm.